In this Fierce Pharma article, Leigh Householder at Syneos Health, shares: “It really is a pivot point. Pharma organizations [should] stand forward as the innovators they’ve always been. Creating change for people, creating longer lives and opportunities for better health.”
Read Article“We don’t all consume the same live TV programming or even streaming services anymore,” Leigh Householder, managing director of omnichannel strategy at Syneos Health shares in this Fierce Pharma article. She talks about personal prime time and programmatic relevance.
Read ArticleSeasoned Talent to Drive Expansion of Solutions at the Intersection of Value and Policy
Read ArticleMedia December 17, 2018
Med Ad News interviewed Sonja Foster-Storch, President of GSW North America and fellow 2018 Manny Award winners for the Healthcare Agency Roundtable highlighted in their December issue.
Media December 14, 2018
Syneos Health conducted research to better understand the burdens created for caregivers and identify specific information on resource gaps that could proactively be addressed by healthcare companies.
Media December 6, 2018
Leigh Householder, EVP / Managing Director of Insights and Innovation at Syneos Health, writes about the uptake of diagnostic tools in this PMLiVE article.
Media November 28, 2018
eBook Provides Biopharma Decision Makers With What’s-Next Insights to Navigate Challenges and Capitalize on the Opportunities Ahead
Media November 27, 2018
This episode of the 2019 Health Trend Ten discusses key clinical trends that will impact the healthcare industry going into 2019.
Media November 27, 2018
The first of the two episodes on the 2019 Health Trend Ten discusses key commercial trends that will impact the healthcare industry going into 2019.
Media November 27, 2018
This article from FiercePharma talks about the release of 2019 Health Trend Ten eBook by Syneos Health, which outlines critical shifts impacting drug development and commercialization.
Media November 9, 2018
This PMLiVE article examines the complexities of human behaviour and what it means for developing behavioural change programmes.
Media October 26, 2018
Meredith Meilinger, VP of Operations at Cadent Medical Communications, a Syneos Health™ company writes about speaker bureaus in this PM360 article.
Media October 25, 2018
Marie Emms, Rowena Kam, and Michael Pearlman of Syneos Health discuss how social media can be used by patients with rare diseases and by those who recruit for rare disease clinical trials.
Media October 22, 2018
This PMLiVE article delves into why collaboration is the best way forward for pharma.
Media October 19, 2018
In autumn last year, we started researching our research paper Artificial Intelligence for Authentic Engagement, informed by a survey of over 1,000 patients and caregivers across the EU and United States. Read more in this PMLiVE article.
Media October 18, 2018
Our Digital & Social Strategy team was at Digital Pharma East. MM&M covers the presentation that highlighted our latest research as outlined in report, Content That Clicks: Effective Social Marketing for Clinical Trial Recruitment.
Media October 17, 2018
Syneos Health Communications, the network of advertising, public relations and medical communications agencies within Syneos Health(TM) (NASDAQ:SYNH), today announced new digital capabilities and talent.
Media October 17, 2018
Original Research to Be Presented at Digital Pharma East
Media October 11, 2018
Pharma has woken up to label optimization. Figuring out, in advance of your pivotal trial, what robust and compelling language you need in your label has become one of the most strategic issues in drug development.
Media October 10, 2018
This PMLiVE article delves into six things that employers can do to retain their best employees.
Media October 5, 2018
Jennifer Kielmeyer, GSW, recaps the DTxDM conference, that brought together more than 200 senior decision-makers from digital therapeutics companies, pharma, investors, payers, and healthcare providers.
Media October 5, 2018
The pharmaceutical and biotech world has a reputation problem, and the practice of using social media to engender trust among stakeholders has been beset by its own recent challenges, as those social channels too have now fallen under public scrutiny.
Media October 4, 2018
Wendy Balter, President, Cadent Medical Communications weighs in on the emerging importance of Connected Opinion Leaders for Medical Marketing & Media.
Media October 2, 2018
This article from the October 2018 issue of PharmaVOICE discusses how pharmaceutical companies are shifting their mindset away from simply selling to physicians and toward serving the patient.
Media October 1, 2018
Leslie Isenegger, Principal Strategist, Risk & Reputation Management, was quoted alongside industry experts about pricing strategies for up-and-coming, innovative medicines. Read it on PharmaVOICE.com.
Media September 21, 2018
Big Data in healthcare isn’t new. But one clear consequence is the enhanced ability to zoom in on the needs of disadvantaged communities and the social determinants of health...
Media September 4, 2018
Data visualization can bridge the gap between information and insight, but only if the particular visualization method chosen is properly matched to the person receiving the information.
Media September 3, 2018
This PharmaTimes article delves into why it is important to go global for the success of clinical trials.
Media August 30, 2018
MM&M sits down with GSW's "creative superheroes" for an honest discussion around creativity.
Media August 2, 2018
This PMLiVE article delves into how pharma can work to enhance its reputation.
Media July 31, 2018
How will the pharma marketing, educational and service model adapt in response to redefined value in immuno-oncology?
Media July 30, 2018
In this article from eyeforpharma's Trends in Patient Centricity magazine, A. J. Triano, our SVP Engagement Strategy and Duncan Arbour, our SVP Strategy, Innovation comment on AI in healthcare.
Media July 26, 2018
The 21st Century Cures Act was passed at the end of 2016 in an effort to accelerate the discovery, development and delivery of new therapies. But what's in it? And what does it mean for biopharma companies?
Already have a RSS feed reader?
